- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Sep 24, 2025
Discovery & Translation
Science Spotlight: Improving genome and transcriptome editors
BioCentury’s translational roundup also includes Roche’s PD-1 x IL-2 fusion, Charcot-Marie-Tooth investment, and three papers from start-ups
BioCentury | Aug 4, 2025
Emerging Company Profile
Tessellate Bio: Identifying new synthetic lethality pairs
Netherlands-based newco aims to extend the concept beyond patients with homologous recombination deficiency
BioCentury | Jan 1, 2021
Targets & Mechanisms
A snapshot of target innovation in 2020
An analysis of BioCentury’s Distillery captures trends from preclinical publications in 2020
BioCentury | Jan 31, 2020
Distillery Therapeutics
Inhibiting SPK2 to treat Middle East respiratory syndrome
Items per page:
1 - 10 of 12